BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10470378)

  • 21. Synergistic release of arachidonic acid from platelets by activators of protein kinase C and Ca2+ ionophores. Evidence for the role of protein phosphorylation in the activation of phospholipase A2 and independence from the Na+/H+ exchanger.
    Halenda SP; Banga HS; Zavoico GB; Lau LF; Feinstein MB
    Biochemistry; 1989 Sep; 28(18):7356-63. PubMed ID: 2554968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lysophosphatidic acid can activate platelets without increasing 32P-labelling of phosphatidic acid.
    Gerrard JM; Robinson P
    Biochim Biophys Acta; 1984 Oct; 795(3):487-92. PubMed ID: 6433985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphatidylinositol hydrolysis by phospholipase A2 and C activities in human peripheral blood neutrophils.
    Smith DM; Waite M
    J Leukoc Biol; 1992 Dec; 52(6):670-8. PubMed ID: 1464738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subcellular distribution of fatty acids, phospholipids and phospholipase A2 in human neutrophils.
    Diez E; Balsinde J; Mollinedo F
    Biochim Biophys Acta; 1990 Oct; 1047(1):83-9. PubMed ID: 2123404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for de novo synthesis of lysophosphatidic acid in the spinal cord through phospholipase A2 and autotaxin in nerve injury-induced neuropathic pain.
    Ma L; Uchida H; Nagai J; Inoue M; Aoki J; Ueda H
    J Pharmacol Exp Ther; 2010 May; 333(2):540-6. PubMed ID: 20123931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet aggregating activity of lysophosphatidic acids is not related to their calcium ionophore properties.
    Simon MF; Chap H; Douste-Blazy L
    FEBS Lett; 1984 Jan; 166(1):115-9. PubMed ID: 6420191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dissociation between the phospholipases C and A2 activities in stimulated platelets and their involvement in the arachidonic acid liberation.
    Faili A; Emadi S; Vargaftig BB; Hatmi M
    Br J Haematol; 1994 Sep; 88(1):149-55. PubMed ID: 7803237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Elevated serum secretory type II phospholipase A2 in patients with coronary heart disease].
    Yu L; Jiang WB; Fu GS; Qin GM; Wang JH; Huang ZQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Sep; 34(9):812-5. PubMed ID: 17217690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperosmotic stress rapidly generates lyso-phosphatidic acid in Chlamydomonas.
    Meijer HJ; Arisz SA; Van Himbergen JA; Musgrave A; Munnik T
    Plant J; 2001 Mar; 25(5):541-8. PubMed ID: 11309144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The formation of [3H]inositol phosphates in human platelets by palmitoyl lysophosphatidic acid is blocked by indomethacin.
    Watson SP; Wolf M; Lapetina EG
    Biochem Biophys Res Commun; 1985 Oct; 132(2):555-62. PubMed ID: 3933504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer.
    Boucharaba A; Serre CM; Grès S; Saulnier-Blache JS; Bordet JC; Guglielmi J; Clézardin P; Peyruchaud O
    J Clin Invest; 2004 Dec; 114(12):1714-25. PubMed ID: 15599396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet secretory phospholipase A2 fails to induce rabbit platelet activation and to release arachidonic acid in contrast with venom phospholipases A2.
    Mounier C; Vargaftig BB; Franken PA; Verheij HM; Bon C; Touqui L
    Biochim Biophys Acta; 1994 Aug; 1214(1):88-96. PubMed ID: 8068732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upregulation of FasL by LPA on ovarian cancer cell surface leads to apoptosis of activated lymphocytes.
    Meng Y; Graves L; Do TV; So J; Fishman DA
    Gynecol Oncol; 2004 Dec; 95(3):488-95. PubMed ID: 15581951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The phospholipase A1 activity of lysophospholipase A-I links platelet activation to LPA production during blood coagulation.
    Bolen AL; Naren AP; Yarlagadda S; Beranova-Giorgianni S; Chen L; Norman D; Baker DL; Rowland MM; Best MD; Sano T; Tsukahara T; Liliom K; Igarashi Y; Tigyi G
    J Lipid Res; 2011 May; 52(5):958-70. PubMed ID: 21393252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The importance of the production of phosphatidic acid for the release of arachidonic acid in stimulated platelets.
    Lapetina EG; Billah MM
    Agents Actions; 1981 Dec; 11(6-7):536-7. PubMed ID: 6803530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calmodulin-independent inhibition of platelet phospholipase A2 by calmodulin antagonists.
    Watanabe T; Hashimoto Y; Teramoto T; Kume S; Naito C; Oka H
    Arch Biochem Biophys; 1986 May; 246(2):699-709. PubMed ID: 3085592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of membrane associated serine esterase in the activation of phospholipase A2 by calcium ionophore (A23187) in pulmonary arterial smooth muscle cells.
    Chakraborti S; Batabyal SK; Michael JR; Sanyal T
    Mol Cell Biochem; 1994 Jan; 130(2):121-7. PubMed ID: 8028591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two pathways for lysophosphatidic acid production.
    Aoki J; Inoue A; Okudaira S
    Biochim Biophys Acta; 2008 Sep; 1781(9):513-8. PubMed ID: 18621144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel Insights in the Regulation of Phosphatidylserine Exposure in Human Red Blood Cells.
    Wesseling MC; Wagner-Britz L; Nguyen DB; Asanidze S; Mutua J; Mohamed N; Hanf B; Ghashghaeinia M; Kaestner L; Bernhardt I
    Cell Physiol Biochem; 2016; 39(5):1941-1954. PubMed ID: 27771709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of phospholipase D in agonist-stimulated lysophosphatidic acid synthesis by ovarian cancer cells.
    Luquain C; Singh A; Wang L; Natarajan V; Morris AJ
    J Lipid Res; 2003 Oct; 44(10):1963-75. PubMed ID: 12837850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.